
Sitagliptin (100mg) + Metformin (1000mg)
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emsita-M SR100/1000 Tablet contains Sitagliptin and Metformin, a combination medication designed to help control blood glucose levels. Sitagliptin enhances the activity of incretin hormones that help regulate insulin release and reduce glucose production after meals. Metformin works by decreasing glucose production in the liver and improving the body’s response to insulin. The sustained release formulation allows the medicine to release gradually, helping maintain stable blood sugar levels for a longer duration. Proper glycemic control is essential for preventing complications related to diabetes and maintaining overall metabolic balance. The medicine is usually taken according to the dosage prescribed by a healthcare professional. Healthy lifestyle measures such as balanced diet, physical activity, and weight management may further support treatment effectiveness. When used as directed, Emsita-M SR100/1000 Tablet helps support effective blood glucose management and improved metabolic health.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita-M SR100/1000 Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Emsita-M SR100/1000 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita-M SR100/1000 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emsita-M SR100/1000 Tablet may be needed. Please consult your doctor. Use of Emsita-M SR100/1000 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita-M SR100/1000 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita-M SR100/1000 Tablet

Sitagliptin (100mg) + Metformin (1000mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emsita-M SR100/1000 Tablet contains Sitagliptin and Metformin, a combination medication designed to help control blood glucose levels. Sitagliptin enhances the activity of incretin hormones that help regulate insulin release and reduce glucose production after meals. Metformin works by decreasing glucose production in the liver and improving the body’s response to insulin. The sustained release formulation allows the medicine to release gradually, helping maintain stable blood sugar levels for a longer duration. Proper glycemic control is essential for preventing complications related to diabetes and maintaining overall metabolic balance. The medicine is usually taken according to the dosage prescribed by a healthcare professional. Healthy lifestyle measures such as balanced diet, physical activity, and weight management may further support treatment effectiveness. When used as directed, Emsita-M SR100/1000 Tablet helps support effective blood glucose management and improved metabolic health.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita-M SR100/1000 Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Emsita-M SR100/1000 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita-M SR100/1000 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emsita-M SR100/1000 Tablet may be needed. Please consult your doctor. Use of Emsita-M SR100/1000 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita-M SR100/1000 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita-M SR100/1000 Tablet













